Business Segments Genomma Lab Internacional, S.A.B. de C.V.
Stocks
LAB B
MX01LA010006
Pharmaceuticals
|
End-of-day quote
Mexican S.E.
2026-09-17
|
5-day change | 1st Jan Change | ||
| 12.57 MXN | +2.28% |
|
-1.41% | -29.74% |
| 09-17 | Genomma Lab Internacional, S.A.B. de C.V. Announces CEO Changes | CI |
| 08-31 | Genomma Lab Internacional, S.A.B. de C.V. Enters Into MXN 1.0 Billion Long-Term Credit Facility With Banamex | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceutical and Personal Care Products Industry | 15.49B | 16.82B | 16.47B | 18.61B | 17.54B | |||||
Total Assets | 21.54B | 21.61B | 20.74B | 23.02B | 23.69B | |||||
Interest Expense | -444M | -526M | -830M | -888M | -797M | |||||
Income Tax Expense | 914M | 868M | 636M | 800M | 820M | |||||
CAPEX | -837M | -422M | -238M | -271M | -548M | |||||
EBT | 2.22B | 2.26B | 1.72B | 2.89B | 2.43B | |||||
Gross Profit | 9.56B | 10.16B | 10.08B | 11.93B | 11.02B | |||||
D&A | 170M | 227M | 227M | 360M | 379M | |||||
Operating Income | 3.05B | 3.25B | 3.26B | 3.92B | 3.76B | |||||
Net Income | 1.31B | 1.39B | 1.08B | 2.09B | 1.61B |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
International | 9.02B | 10.07B | 8.43B | 9.72B | 9.66B | |||||
Total Assets | 5.5B | 6.48B | 5.97B | 8.57B | 7.75B | |||||
Interest Expense | -136M | -102M | -148M | -212M | -159M | |||||
Income Tax Expense | 500M | 483M | 286M | 184M | 425M | |||||
D&A | 77.7M | 76.53M | 64.88M | 86.43M | 110M | |||||
CAPEX | -103M | -49.64M | -48.8M | - | -72.31M | |||||
Net Income | 878M | 1.03B | 647M | 714M | 936M | |||||
| - | - | - | - | 7.89B | ||||||
Mexico | 6.46B | 6.75B | 8.04B | 8.88B | 7.89B | |||||
Total Assets | 16.04B | 15.12B | 14.77B | 14.44B | 15.94B | |||||
Interest Expense | -309M | -424M | -682M | -676M | -638M | |||||
Income Tax Expense | 414M | 384M | 350M | 616M | 394M | |||||
D&A | 92.56M | 151M | 162M | 273M | 269M | |||||
CAPEX | -733M | -373M | -279M | - | -502M | |||||
Net Income | 429M | 363M | 438M | 779M | 678M | |||||
| - | - | - | - | 9.66B |
Select your edition
All financial news and data tailored to specific country editions
